Add to ORKGhyperthermia W Neoadjuvant chemotherapy For high-risk soft tissue sarcomas (HR-STS) of adults, new treatment strategies are needed to improve out-come with regard to local control and overall survival. Therefore, systemic chemotherapy has been integrated either after (adjuvant) or before (neoadjuvant) optimal local treatment by surgery and radiotherapy in HR-STS. The combination with regional hyperthermia as a new treatment strategy seems to open a new therapeutic win-dow. Copyright © 2003 S. Karger AG, Basel High-Risk Soft Tissue Sarcomas Soft tissue sarcomas (STS) represent a heterogeneous group of relatively rare malignancies with a wide spec
Soft tissue sarcomas are a rare and multifaceted group of solid tumours. Neoadjuvant chemotherapy is...
Background: Recurrence after wide excision or residual tumor after an unplanned excision of a malign...
BACKGROUND: The use of neoadjuvant and adjuvant chemotherapy in soft tissue sarcomas is controversia...
For high-risk soft tissue sarcomas (HR-STS) of adults, new treatment strategies are needed to improv...
Purpose: To determine the efficacy of neoadjuvant chemotherapy combined with regional hyperthermia (...
Purpose: For high-risk soft tissue sarcoma (HR-STS) of adults new treatment strategies are needed to...
Purpose: Localized adult high-grade soft tissue sarcomas (STS) usually require multimodality treatme...
BACKGROUND: The optimum treatment for high-risk soft-tissue sarcoma (STS) in adults is unclear. Regi...
Patients with high-risk soft tissue sarcomas (STS)-FNCLCC grade 2-3, size >5 cm, deep to the fascia-...
In this phase II study, activity and safety of neoadjuvant regional hyperthermia (RHT) combined with...
Background The optimum treatment for high-risk soft-tissue sarcoma (STS) in adults is undear. Region...
Opinion statement: Adult-type soft tissue sarcomas (STS) are curable in roughly one half of cases. S...
PURPOSE: We report data from phase II trials examining the efficacy of multimodality treatment with ...
The efficacy of thermochemotherapy in adult patients with primary, recurrent or inadequately resecte...
On the basis of the definition of high-risk soft tissue sarcomas and prognostic factors, the most re...
Soft tissue sarcomas are a rare and multifaceted group of solid tumours. Neoadjuvant chemotherapy is...
Background: Recurrence after wide excision or residual tumor after an unplanned excision of a malign...
BACKGROUND: The use of neoadjuvant and adjuvant chemotherapy in soft tissue sarcomas is controversia...
For high-risk soft tissue sarcomas (HR-STS) of adults, new treatment strategies are needed to improv...
Purpose: To determine the efficacy of neoadjuvant chemotherapy combined with regional hyperthermia (...
Purpose: For high-risk soft tissue sarcoma (HR-STS) of adults new treatment strategies are needed to...
Purpose: Localized adult high-grade soft tissue sarcomas (STS) usually require multimodality treatme...
BACKGROUND: The optimum treatment for high-risk soft-tissue sarcoma (STS) in adults is unclear. Regi...
Patients with high-risk soft tissue sarcomas (STS)-FNCLCC grade 2-3, size >5 cm, deep to the fascia-...
In this phase II study, activity and safety of neoadjuvant regional hyperthermia (RHT) combined with...
Background The optimum treatment for high-risk soft-tissue sarcoma (STS) in adults is undear. Region...
Opinion statement: Adult-type soft tissue sarcomas (STS) are curable in roughly one half of cases. S...
PURPOSE: We report data from phase II trials examining the efficacy of multimodality treatment with ...
The efficacy of thermochemotherapy in adult patients with primary, recurrent or inadequately resecte...
On the basis of the definition of high-risk soft tissue sarcomas and prognostic factors, the most re...
Soft tissue sarcomas are a rare and multifaceted group of solid tumours. Neoadjuvant chemotherapy is...
Background: Recurrence after wide excision or residual tumor after an unplanned excision of a malign...
BACKGROUND: The use of neoadjuvant and adjuvant chemotherapy in soft tissue sarcomas is controversia...